Lixte Biotechnology H -CW25LIXTWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders +1
1new positions
0sold out
1famous investor
$0.03avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Lixte Biotechnology H -CW25 (LIXTW) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($880), Clear Street LLC ($766) and Bank of America Corp. ($2). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Lixte Biotechnology H -CW25
- CUSIP
- 539319111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 200 shares bought and 1,300 shares sold, net −1,100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Reduce -4.8% | 26,032 | $880 |
| Clear Street LLC | — | Add +0.4% | 22,654 | $766 |
| Bank of America Corp. | — | New | 100 | $2 |
"% of holder's portfolio" is LIXTW's weight in each manager's 13F, not the share of Lixte Biotechnology H -CW25 the manager owns.